Page 1 | Search Results | Blood | American Society of Hematology

1-19 of 19

Sort by

Sort Order Select

Journal Articles

Clinical Outcomes after Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Transfusion-Dependent β-Thalassemia Treated at the Bambino Gesù Children's Hospital, Rome, Italy

Pietro Merli, MD, Annalisa Ruggeri, MD, Mattia Algeri, MD, Giuseppina Li Pira, PhD, Giulia Ceglie, MD, Katiana Gruppioni, MPH, Sanjeev Kommera, MS, Jenfue Maa, PhD, Franco Locatelli, MD PhD

Blood (2019) 134 (Supplement_1): 969.

https://doi.org/10.1182/blood-2019-123440

Published: 2019

Journal Articles

A Laboratory Based Scoring System Predicts Early Treatment in Rai 0/Binet a CLL

Blood (2018) 132 (Supplement 1): 4399.

https://doi.org/10.1182/blood-2018-99-112162

Published: 2018

Journal Articles

Impact of Previous Invasive Fungal Infections on the Outcome of Patients Undergoing Allogeneic Hematopoietic Stem Cells

Gaetano Maffongelli, Sr., PhD, Gaetano Maffongelli, Sr., PhD, Gaetano Maffongelli, Sr., PhD, Laura Cudillo, MD, Fabio Di Piazza, MSc, Vincenzo Malagnino, Giovanna de Santis, Benedetta Mariotti, Eleonora Ceresoli, Raffaella Cerretti, MD, Alessandra Picardi, MD, Massimo Andreoni, William Arcese, MD, Loredana Sarmati

Blood (2016) 128 (22): 5748.

https://doi.org/10.1182/blood.V128.22.5748.5748

Published: 2016

Journal Articles

Cost Description on a Cohort of 659 Patients with Adult MDS Included into the Italian Lazio Region Registry (the GROM-L)

Carlo Lazzaro, Dr., Maria Antonietta Aloe-Spiriti, MD, Maria Teresa Voso, MD, Roberto Latagliata, MD, Francesco Buccisano, MD, Susanna Fenu, MD, Luca Maurillo, MD, Roberto Ricci, Dr., Luana Fianchi, Gina Zini, MD Prof.

Blood (2015) 126 (23): 5237.

https://doi.org/10.1182/blood.V126.23.5237.5237

Published: 2015

Journal Articles

Survival of Patients with High Risk Hematological Malignancy after Allogeneic Transplant from HLA Identical Siblings Is Comparable to That of Patients Transplanted from Haploidentical, Unmanipulated Bone Marrow Donor: Results of a Matched-Pair Analysis from the Rome Transplant Network

Blood (2014) 124 (21): 1223.

https://doi.org/10.1182/blood.V124.21.1223.1223

Published: 2014

Journal Articles

All Roads Lead to Rome: Phenotypic Channeling to Uniform Differentiation Structures from Diverse Leukemia Genotypes by Mass Cytometry

Garry Nolan, PhD

Blood (2013) 122 (21): SCI-22.

https://doi.org/10.1182/blood.V122.21.SCI-22.SCI-22

Published: 2013

Journal Articles

Response: increased expression or activity of PTPN22 may compromise negative selection of autoreactive CLL cells

Dimitar G. Efremov

Blood (2013) 121 (1): 238–239.

https://doi.org/10.1182/blood-2012-10-459776

Published: 2013

Journal Articles

The Incidence of Central Nervous System Involvement in AML: A SAL-Tor Vergata Analysis

Nael Alakel, MD, Maria Ilaria Del Principe, Friedrich Stölzel, MD, Brigitte Mohr, Uta Oelschlaegel, PhD, Sergio Amadori, MD, Gerhard Ehninger, MD, Adriano Venditti, M.D., Markus Schaich, MD

Blood (2011) 118 (21): 4236.

https://doi.org/10.1182/blood.V118.21.4236.4236

Published: 2011

Journal Articles

T-Cell Receptor Gene Deletions Are Associated with High Risk Features and Worse Outcome In Childhood Precursor B-Cell Acute Lymphoblastic Leukemia (ALL)

Jonathan Downie, BS, Phillip Barnette, MD, Vladimir Rodic, BS, J. Kimble Frazer, MD, PhD, Nikolaus Trede, MD, PhD, Meenakshi Devidas, PhD, Charles Mullighan, MBBS, MD, FRACP, FRCPA, MSc, Stephen Hunger, MD, Rodney R. Miles, MD, PhD, Joshua D. Schiffman, MD

Blood (2010) 116 (21): 275.

https://doi.org/10.1182/blood.V116.21.275.275

Published: 2010

Journal Articles

Incidence and Predictors of Early Treatment-Related Mortality In Pediatric Acute Lymphoblastic Leukemia In Baghdad (Iraq)

Anna Maria Testi, Robin Foa, Mazin Faisal Al-Jadiry, Maria Luisa Moleti, Salma Abbas Al-Hadad, Jawad Kadhum Al-Taee, Wisam Majeed Abed, Najiha Ahmed Ameen, Hasanein H. Ghali, Amir Fadhil Al-Darraji, Raghad Majid Al-Saeed, Valerio Cecinati, Annalisa De Vellis, Alfonso Piciocchi

Blood (2010) 116 (21): 2132.

https://doi.org/10.1182/blood.V116.21.2132.2132

Published: 2010

Journal Articles

A Retrospective Epidemiological Analysis of 1572 Cases of Ph1- Myeloprolypherative Neoplasms (MPNs) From 9 Centers In the Latium: Preliminary Results

Blood (2010) 116 (21): 5065.

https://doi.org/10.1182/blood.V116.21.5065.5065

Published: 2010

Journal Articles

“An Intention-to-Treat Analysis of Rome Transplant Network Policy for Alternative Donor Search in Patients Lacking a HLA Matched Related donor”.

Blood (2009) 114 (22): 1195.

https://doi.org/10.1182/blood.V114.22.1195.1195

Published: 2009

Journal Articles

Embrio-Foetal Erythroid Precursors in the Coelomic Fluid From Humans.

Maria Concetta Renda, PhD, Antonino Giambona, PhD, Emanuela Fecarotta, PhD, Filippo Leto, Tech, George Makrydimas, MD, Disma Renda, MD, Gianfranca Damiani, MD, Maria Cristina Jakil, MD, Francesco Picciotto, MD, Mauro Valtieri, MD, Tiziana Piazza, PhD, Aurelio Maggio, MD

Blood (2009) 114 (22): 5086.

https://doi.org/10.1182/blood.V114.22.5086.5086

Published: 2009

Journal Articles

Line Treatment of Adult Ph+ Acute Lymphoblastic Leukemia (ALL) Patients. Final Results of the GIMEMA LAL1205 Study

Blood (2008) 112 (11): 305.

https://doi.org/10.1182/blood.V112.11.305.305

Published: 2008

Journal Articles

ATM Gene Alterations in CLL Patients Induce Gene Profile Clusters and Predict Disease Progression.

Anna Guarini, Marilisa Marinelli, Simona Tavolaro, Isabella Torrente, Emanuele Bellacchio, Monia Magliozzi, Simona Santangelo, Nadia Peragine, Maria Stefania De Propris, Mauro Nanni, Sabina Chiaretti, Francesca Romana Mauro, Ilaria Del Giudice, Bruno Dallapiccola, Robert Foa

Blood (2008) 112 (11): 2084.

https://doi.org/10.1182/blood.V112.11.2084.2084

Published: 2008

Journal Articles

Standard Versus High Dose Lenograstim in Adults with Hematological Malignancies for Peripheral Blood Progenitor Cell Mobilization: Results of a Retrospective Study on Behalf of Rome Transplant Network.

Azzurra Anna Romeo, Anna Chierichini, Diana Giannarelli, Alessandra Spagnoli, Barbara Anaclerico, Mariangela Vittori, Michele Vacca, Maria Gozzer, Antonio Spadea, MD, PhD, Luciana Annino, Maria Concetta Petti, Andrea Mengarelli, William Arcese, MD

Blood (2008) 112 (11): 2302.

https://doi.org/10.1182/blood.V112.11.2302.2302

Published: 2008

Journal Articles

Early Response to Therapy Is Significantly Associated with Genetic Subtype of Acute Lymphoblastic Leukemia: A Report from the Children’s Oncology Group.

Mignon L. Loh, MD, Elizabeth Raetz, M.D., Meenakshi Devidas, Ph.D., Stephen B. Linda, Ph.D., Michael J. Borowitz, M.D, Andrew J. Carroll, M.D., I.-Ming L. Chen, Julie M. Gastier-Foster, Ph.D., Nyla A. Heerema, Ph.D, Richard C. Harvey, Ph.D, Eric Larsen, M.D., Kelly Maloney, M.D., Cheryl L. Willman, M.D., Naomi Winick, M.D., Brent Wood, M.D., Stephen P. Hunger, M.D., William L. Carroll, M.D.

Blood (2007) 110 (11): 758.

https://doi.org/10.1182/blood.V110.11.758.758

Published: 2007

Journal Articles

Prospective analysis of TEL/AML1 -positive patients treated on Dana-Farber Cancer Institute Consortium Protocol 95-01

Mignon L. Loh, Meredith A. Goldwasser, Lewis B. Silverman, Wing-Man Poon, Shashaank Vattikuti, Angelo Cardoso, Donna S. Neuberg, Kevin M. Shannon, Stephen E. Sallan, D. Gary Gilliland

Blood (2006) 107 (11): 4508–4513.

https://doi.org/10.1182/blood-2005-08-3451

Published: 2006

Journal Articles

Early Marrow Response in CCG-1952: The Prognostic Impact of Poor Day 14 Marrow Response Is Powerful and Only Partially Reversible with Intensified Therapy.

Robert Cho, MD, Linda C. Stork, MD, Paul S. Gaynon, MD, Harland N. Sather, PhD, Mei K. La, MS, Raymond J. Hutchinson, MD

Blood (2005) 106 (11): 867.

https://doi.org/10.1182/blood.V106.11.867.867

Published: 2005

NARROW

Clinical Outcomes after Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Transfusion-Dependent β-Thalassemia Treated at the Bambino Gesù Children's Hospital, Rome, Italy

A Laboratory Based Scoring System Predicts Early Treatment in Rai 0/Binet a CLL

Impact of Previous Invasive Fungal Infections on the Outcome of Patients Undergoing Allogeneic Hematopoietic Stem Cells

Cost Description on a Cohort of 659 Patients with Adult MDS Included into the Italian Lazio Region Registry (the GROM-L)

Survival of Patients with High Risk Hematological Malignancy after Allogeneic Transplant from HLA Identical Siblings Is Comparable to That of Patients Transplanted from Haploidentical, Unmanipulated Bone Marrow Donor: Results of a Matched-Pair Analysis from the Rome Transplant Network

All Roads Lead to Rome: Phenotypic Channeling to Uniform Differentiation Structures from Diverse Leukemia Genotypes by Mass Cytometry

Response: increased expression or activity of PTPN22 may compromise negative selection of autoreactive CLL cells

The Incidence of Central Nervous System Involvement in AML: A SAL-Tor Vergata Analysis

T-Cell Receptor Gene Deletions Are Associated with High Risk Features and Worse Outcome In Childhood Precursor B-Cell Acute Lymphoblastic Leukemia (ALL)

Incidence and Predictors of Early Treatment-Related Mortality In Pediatric Acute Lymphoblastic Leukemia In Baghdad (Iraq)

A Retrospective Epidemiological Analysis of 1572 Cases of Ph1- Myeloprolypherative Neoplasms (MPNs) From 9 Centers In the Latium: Preliminary Results

“An Intention-to-Treat Analysis of Rome Transplant Network Policy for Alternative Donor Search in Patients Lacking a HLA Matched Related donor”.

Embrio-Foetal Erythroid Precursors in the Coelomic Fluid From Humans.

Line Treatment of Adult Ph+ Acute Lymphoblastic Leukemia (ALL) Patients. Final Results of the GIMEMA LAL1205 Study

ATM Gene Alterations in CLL Patients Induce Gene Profile Clusters and Predict Disease Progression.

Standard Versus High Dose Lenograstim in Adults with Hematological Malignancies for Peripheral Blood Progenitor Cell Mobilization: Results of a Retrospective Study on Behalf of Rome Transplant Network.

Early Response to Therapy Is Significantly Associated with Genetic Subtype of Acute Lymphoblastic Leukemia: A Report from the Children’s Oncology Group.

Prospective analysis of TEL/AML1 -positive patients treated on Dana-Farber Cancer Institute Consortium Protocol 95-01

Early Marrow Response in CCG-1952: The Prognostic Impact of Poor Day 14 Marrow Response Is Powerful and Only Partially Reversible with Intensified Therapy.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only